Stockholders' Equity - Additional Information (Details) - USD ($)		1 Months Ended		3 Months Ended		6 Months Ended
	May 12, 2025	Nov. 30, 2024	Mar. 31, 2024	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	May 31, 2025	Dec. 31, 2024	Jun. 03, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock purchase, aggregate principal amount				$ 311,000	$ 288,000
Common stock par value (in dollars per share)				$ 0.01		$ 0.01			$ 0.01
Net proceeds from offering						$ 3,263,000	$ 16,183,000
Common stock, shares issued (in shares)				28,423,611		28,423,611			27,617,415
Sixth Amended And Restated 2013 Incentive Compensation Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)								700,000
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)								700,000		400,000
Purchase plan, shares purchased (in shares)						30,610
Purchase plan, per share weighted average price of shares purchased (in usd per share)				$ 10.15		$ 10.15
Public Offering
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Public offering (in shares)			2,653,848
Common stock initially offered at public offering (in shares)			2,307,694
Sale of stock, price per share (in usd per share)			$ 6.5
Net proceeds from offering			$ 16,200,000
Shares sold pursuant to exercise of underwriters option (in shares)			346,154
At-The-Market Equity Offering
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock maximum proceeds on potential common stock offering		$ 50,000,000
Common stock, shares issued (in shares)				0		0
2025 Stock Purchase Agreement \| 2025 Investor
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock purchase, aggregate principal amount	$ 275,808
Common stock par value (in dollars per share)	$ 0.01
Sale of stock, price per share (in usd per share)	$ 12.69
Net proceeds from offering	$ 3,300,000

ClearPoint Neuro, Inc. 10-Q